We discovered that TMEM106C is highly expressed in HCC, and biological validation demonstrated that the overexpression of TMEM106C may contribute to the proliferation and metastasis of HCC by targeting CENPM and DLC-1. The gene discussed is CENPM; the disease is hepatocellular carcinoma.